Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable knowledge share and facilitate idea exchange.

If you have a cutting edge case study or relevant presentation and would like to join the speaker panel at one of our events, please contact Cerlin Roberts on c.roberts@oxfordglobal.co.uk

Biomarkers & Precision Medicine USA Congress 2018 Speakers:

Stefan Scherer, Vice President, Global Head Correlative Science
Novartis

Alessandra Di Bacco, Senior Director, Translational Medicine
Takeda

Lars Bukhave Rasmussen, Vice President, Head of Marketing (Patient Solitions)
LEO Pharma Inc.

John Allinson, Vice President
BDS

Rajiv Raja, Director, Translational Sciences
MedImmune

Nuzhat Pathan, Director, Translational Oncology
Pfizer

Daniela Ennulat, Director of Pathology and Senior Science Fellow In Vitro In Vivo Translation
GlaxoSmithKline

Emmanuelle di Tomaso, Head of Translational Medicine
Syros

Katherine Call, Senior Director & Head, Proteogenomics Translational Sciences
Sanofi

Jane Wang, Director, TM CVMD, CVMD iMED
MedImmune/ AstraZeneca

Deepak Khatry, Science Associate Director, Statistical Sciences
MedImmune

Ernesto Munoz, Associate Director & Head of Biomarkers, Immunodermatology
Johnson & Johnson

Jennifer Burkey, Scientific Director, Predictive Safety Testing Consortium
Critical Path Institute

Dave Hoon, Director Molecular Oncology,
John Wayne Cancer Institute

Ken Chang, Director, Clinical Biomarkers
Daiichi Sankyo, Inc

Zhenhao Qi, Associate Director, Clinical Genetics & Genomics in Translational Medicine
Bristol-Myers Squibb

Elizabeth Somers, Director Diagnostics
Morphotek

Ajit Dash, Safety Science Associate Medical Director, Licensing and Early Development (LEAD) Safety – Non Oncology
Genentech

James Snider, Chief Scientific Officer and President
Critical Diagnostics

Robin Marsden, Associate Director, Bioanalytical
La Jolla Pharmaceutical Company

Stefan Kostense, Director Prevention Biomarker
Janssen

Pavan Kumar, Director of Biomarkers and Companion Diagnostics,
H3 Biomedicine

Nathan Hedrick, Director, Clinical Cytometry, CTTO, ECTR
Bristol-Myers Squibb

Tanja Zabka, Lead Safety Biomarker & Comparative Oncology Initiatives
Genentech

Allison Vitsky, Associate Research Fellow, Global Biomarkers, Drug Safety Research and Development
Pfizer

Mark Ma, Head of Biomarkers and Bioanalytics
Alexion

Xuemei Zhao, Senior Principal Scientist
Merck

Sheng Feng, Senior Principal Research Statistician
AbbVie

Keith Tanis, Principal Scientist, Genetics & Pharmacogenomics
Merck

Kevin Halling, Professor of Laboratory Medicine and Pathology
Mayo Clinic

Ronald M. Przygodzki, Director, Genomic Medicine Implementation, Associate Director, Genomic Medicine, Office of Research and Development
US Department of Veterans Affairs

Tony Jun Huang, Professor of Mechanical Engineering and Materials Science (MEMS) and Biomedical Engineering (BME)
Pratt School of Engineering, Duke University

John Nolan, Professor
Nolan Lab – Scintillon Institute